Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase III trial in mantle cell lymphoma.

Authors:

Ferrero S, Grimaldi D, Genuardi E, Drandi D, Zaccaria GM, Alessandria B, Ghislieri M, Ferrante M, Evangelista A, Mantoan B, De Luca G, Stefani PM, Benedetti F, Casaroli IR, Zanni M, Castellino C, Pavone V, Petrini M, Re F, Hohaus S, Musuraca G, Cascavilla N, Ghiggi C, Liberati AMM, Cortelazzo S, Ladetto M.

 

Journal:

Blood 2022; 140: 1378-1389. doi: 10.1182/blood.2021014270. PMID: 35737911 (IF 25.476)

Year:
2022
Kind:
Articoli

This site uses technical, analytics and third-party cookies. By continuing to browse, you accept the use of cookies.